Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DR26F8Y4R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,242
Award facts
- Contract value 100% obligated
- $19,242.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,242.13 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company holds a significant position within the federal medical supply chain, regularly winning competitively awarded contracts across the Defense Logistics Agency's medical procurement programs. This delivery order is one of numerous transactions through which AmerisourceBergen supplies critical medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the contractor's established capability to meet federal pharmaceutical requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F8Y4R?
SPE2DR26F8Y4R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F8Y4R worth?
The government has obligated $19,242 on SPE2DR26F8Y4R.
Is contract SPE2DR26F8Y4R an order under another contract?
Yes. SPE2DR26F8Y4R is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y4R competed?
The extent of competition for SPE2DR26F8Y4R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award